The report provides a detailed analysis essential for establishing a Clorazepate production plant. It encompasses all critical aspects necessary for Clorazepate production, including the cost of Clorazepate production, Clorazepate plant cost, Clorazepate production costs, and the overall Clorazepate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Clorazepate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Clorazepate is a medication belonging to the benzodiazepine group and is mainly used for its calming and muscle-relaxing effects. It is primarily prescribed for the treatment of anxiety disorders, where it helps reduce nervousness, tension, and restlessness. It is also used in the management of seizure disorders, especially as an add-on therapy to control epilepsy.
It acts by enhancing the binding of gamma-aminobutyric acid to GABA-A receptors, which promotes channel opening and neuronal hyperpolarisation, thereby producing depressant effects on the central nervous system. It is also commonly used in the management of alcohol withdrawal symptoms, which helps to ease agitation, tremors, and restlessness. It is often used in combination with other antiepileptic medicines for controlling certain types of seizures. It is also sometimes used as a short-term treatment for insomnia or sleep disturbances linked with stress or anxiety.
The market for Clorazepate is primarily driven by its application as an anxiolytic and anticonvulsant medication for the treatment of anxiety disorders, which promotes its demand in the pharmaceutical industry. Its application as a drug to relieve alcohol withdrawal symptoms, helping patients manage agitation and tremors during detoxification, further boosts its demand in the healthcare and pharmaceutical industry.
Its demand as a short-term sedative to support patients with sleep disturbances related to anxiety also strengthens its market growth. Industrial Clorazepate procurement is affected by factors including the availability and quality of chemical intermediates, compliance with controlled substance regulations, and adherence to pharmaceutical safety standards. In addition, production reliability, supplier consistency, regulatory approvals, and secure logistics systems also play an important role in shaping global procurement trends and the overall market for Clorazepate.
Raw Material for Clorazepate Production
According to the Clorazepate production plant project report, the major raw materials for Clorazepate production include 2-Amino-5-chlorobenzonitrile, Phenylmagnesium Bromide, Diethyl Aminomalonate, and Potassium Hydroxide.
Production Process of Clorazepate
The extensive Clorazepate production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of Clorazepate begins with the Grignard reaction of 2-amino-5-chlorobenzonitrile using phenylmagnesium bromide, which forms a ketimine intermediate. Then, the obtained ketimine undergoes condensation with diethyl aminomalonate through loss of ammonia, which results in a diester compound. The diester is treated with potassium hydroxide in aqueous methanol to saponify the ester groups, which form a dipotassium salt of the dicarboxylic acid. Further, this intermediate cyclizes through isomerisation to produce Clorazepate as the final product.
Clorazepate is a benzodiazepine medication that functions as a prodrug and is rapidly decarboxylated to nordiazepam, its active metabolite, which is responsible for most of its therapeutic effects. It appears as a white to light yellow crystalline powder that is solid at room temperature and is odourless. The molecular formula of the free acid form is C16H11ClN2O3, and its molecular mass is 314.72 g/mol. The density of clorazepate is approximately 1.52 g/cm³, and the melting point is around 236 degree Celsius. Its melting point is around 228-235 degree Celsius, and it is very soluble in water. The compound should be stored at 20 to 25 degree Celsius in tightly closed containers protected from moisture and light, and under nitrogen in airtight containers. Common side effects include sedation, drowsiness, dizziness, ataxia, confusion, cognitive impairment, anterograde amnesia, and falls in the elderly. It is contraindicated in patients with acute narrow-angle glaucoma, severe respiratory insufficiency, and known hypersensitivity to benzodiazepines.